Xoma | XOMA - Capitaux Propres Et Réserves



Capitaux Propres Et Réserves Changement Date
AbbVie USD -4.58B 1.35B 2026-09
Agenus USD -199.08M 22.15M 2026-06
Agios Pharmaceuticals USD 979.34M 46.68M 2026-09
Ardelyx USD 164.05M 15.03M 2026-09
aTyr Pharma USD 33.98M 14.81M 2026-09
BioMarin Pharmaceutical USD 6.26B 65.66M 2026-09
Celldex Therapeutics USD 649.47M 65.1M 2026-09
Curis USD 12.71M 7.24M 2026-03
Eli Lilly USD 40.27B 6.39B 2026-09
Emergent BioSolutions USD 649.3M 47.9M 2023-12
Incyte USD 5.64B 701.49M 2026-09
MacroGenics USD 42.87M 21.68M 2026-06
Novartis USD 37.23B 4.72B 2026-09
Novartis USD 37.56B 1.36B 2026-09
Pfizer USD 89B 3.81B 2026-09
Prothena USD 268.84M 18.05M 2026-09
Regeneron Pharmaceuticals USD 33.5B 1.79B 2026-09